Novozymes (NSISBC) Stock Overview
Produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
NSISBC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Novozymes A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 415.00 |
| 52 Week High | DKK 484.90 |
| 52 Week Low | DKK 376.50 |
| Beta | 0.81 |
| 1 Month Change | 2.80% |
| 3 Month Change | 0.74% |
| 1 Year Change | 5.36% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 2.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| NSISBC | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | -0.6% | 1.8% | 1.3% |
| 1Y | 5.4% | 4.4% | 20.7% |
Return vs Industry: NSISBC matched the UK Chemicals industry which returned 4.4% over the past year.
Return vs Market: NSISBC underperformed the UK Market which returned 20.7% over the past year.
Price Volatility
| NSISBC volatility | |
|---|---|
| NSISBC Average Weekly Movement | 4.4% |
| Chemicals Industry Average Movement | 6.2% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: NSISBC has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: NSISBC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1925 | 10,582 | Ester Baiget | www.novonesis.com |
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Novozymes A/S Fundamentals Summary
| NSISBC fundamental statistics | |
|---|---|
| Market cap | DKK 194.76b |
| Earnings (TTM) | DKK 4.09b |
| Revenue (TTM) | DKK 30.95b |
Is NSISBC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NSISBC income statement (TTM) | |
|---|---|
| Revenue | €4.14b |
| Cost of Revenue | €1.72b |
| Gross Profit | €2.43b |
| Other Expenses | €1.88b |
| Earnings | €547.00m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 25, 2026
| Earnings per share (EPS) | 1.17 |
| Gross Margin | 58.55% |
| Net Profit Margin | 13.20% |
| Debt/Equity Ratio | 28.9% |
How did NSISBC perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/18 08:15 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Novozymes A/S is covered by 33 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sebastian Satz | Barclays |
| Cezara Lozneanu | Barclays |
| Alexander Sloane | Barclays |